Category: Hypertension

Predictive Role of Biomarkers in COVID-19 Mortality

Posted on | Posted on John Murphy | Leave a Comment on Predictive Role of Biomarkers in COVID-19 Mortality

Ayşe Yılmaz,1 Öztürk Taşkın,1 Ufuk Demir,1 and Veysel G Soylu2 Cureus. 2023 Jan; 15(1): e34173. Published online 2023 Jan 24 doi: 10.7759/cureus.34173 PMCID: PMC9950690PMID: 36843833 Abstract Background The coronavirus disease 2019 (COVID-19) pandemic has resulted in high mortality among patients in critical intensive care units. Hence, identifying mortality markers in the follow-up and treatment of these patients is essential. This study aimed to evaluate […]

Incidence of New-Onset Hypertension Post–COVID-19: Comparison With Influenza

Posted on | Posted on John Murphy | Leave a Comment on Incidence of New-Onset Hypertension Post–COVID-19: Comparison With Influenza

Vincent Zhang, Molly Fisher,Wei Hou,Lili Zhang and Tim Q. Duong      Aug 2023 Hypertension. 2023;0 Abstract BACKGROUND: SARS-CoV-2 may trigger new-onset persistent hypertension. This study investigated the incidence and risk factors associated with new-onset persistent hypertension during COVID-19 hospitalization and at ≈6-month follow-up compared with influenza. METHODS: This retrospective observational study was conducted in a major […]

‘Alarming’ study finds Covid can trigger high blood pressure

Posted on | Posted on John Murphy | Leave a Comment on ‘Alarming’ study finds Covid can trigger high blood pressure

Katherine Fidler  21 Aug 2023 3:02 pm Covid-19 may cause high blood pressure in those previously unaffected by the disorder, a new study suggests. The ‘alarming’ research found that of more than 45,000 patients attending hospital due Covid with no history of hypertension, a significant number went on to develop high blood pressure within six […]

Conflicting Evidence Of mRNA Technology Raises Serious Concerns About Rush For Use In New Vaccine Development

Posted on | Posted on John Murphy | Leave a Comment on Conflicting Evidence Of mRNA Technology Raises Serious Concerns About Rush For Use In New Vaccine Development

Authored by Megan Redshaw via The Epoch Times, FRIDAY, SEP 01, 2023 The U.S. government and pharmaceutical companies are investing a substantial amount to develop new mRNA vaccines for infectious diseases and cancer, fueling a lucrative mRNA platform valued at $136.2 billion. A newly established White House program announced on Aug. 23 that it is granting a […]

Does COVID-19 Cause Hypertension?

Posted on | Posted on John Murphy | Leave a Comment on Does COVID-19 Cause Hypertension?

Authors: Mahmut Akpek, MD  December 10, 2021 Research Article https://doi.org/10.1177/00033197211053903 Abstract The coronavirus disease 2019 (COVID-19) outbreak remains a major public health challenge worldwide. The present study investigated the effect of COVID-19 on blood pressure (BP) during short term follow-up. A total of 211 consecutive COVID-19 patients who were admitted to Parkhayat Kutahya hospital were retrospectively screened. […]

Long-term cardiovascular outcomes of COVID-19

Posted on | Posted on John Murphy | Leave a Comment on Long-term cardiovascular outcomes of COVID-19

Authors: Yan Xie, Evan Xu, Benjamin Bowe & Ziyad Al-Aly  Nature Medicine (2022) Abstract The cardiovascular complications of acute coronavirus disease 2019 (COVID-19) are well described, but the post-acute cardiovascular manifestations of COVID-19 have not yet been comprehensively characterized. Here we used national healthcare databases from the US Department of Veterans Affairs to build a cohort of 153,760 individuals with […]

Clinical determinants of the severity of COVID-19: A systematic review and meta-analysis

Posted on | Posted on John Murphy | Leave a Comment on Clinical determinants of the severity of COVID-19: A systematic review and meta-analysis

Authors: Xinyang Li, Xianrui Zhong, Yongbo Wang, Xiantao Zeng, Ting Luo, Qing Liu  Published: May 3, 2021 Abstract Objective We aimed to systematically identify the possible risk factors responsible for severe cases. Methods We searched PubMed, Embase, Web of science and Cochrane Library for epidemiological studies of confirmed COVID-19, which include information about clinical characteristics […]

Severe COVID-19: what have we learned with the immunopathogenesis?

Posted on | Posted on John Murphy | Leave a Comment on Severe COVID-19: what have we learned with the immunopathogenesis?

Authors: Bruno Bordallo,  Mozart Bellas, Arthur Fernandes Cortez, Matheus Vieira & Marcelo Pinheiro  Advances in Rheumatology volume 60, Article number: 50 (2020) Cite this article Abstract The COVID-19 outbreak caused by severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) has become a global major concern. In this review, we addressed a theoretical model on immunopathogenesis associated with severe COVID-19, based on the current literature of SARS-CoV-2 […]